Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Financial News
    Large Cap Stocks
    Small-Cap Stocks
    Insider Trades
    Earnings
    Technology
    AI News
    Personal Finance
    ETF News
    Crypto News
    Dividend News
    Latest Rumors
    Latest Offerings News
  • Investment Ideas
    Investment Ideas
    Stock of the Day
    Stock Whisper Index
    Analyst Ratings
    Analyst Color
    Financial Advisors
    Government Trades
    Trading Ideas
    Stock Screener
  • Markets
    Markets
    Premarket Movers
    After Hours
    Options
    ETFs
    Commodities
    Prediction Markets
    Private Markets
    Bonds
    Futures
    Forex
  • Top Stocks
    Top Stocks
    Apple (AAPL)
    Tesla (TSLA)
    Amazon (AMZN)
    Nvidia (NVDA)
    Alphabet (GOOGL)
    Meta Platforms (META)
    Microsoft (MSFT)
    StreetTracks Gold Shares (GLD)
    IBIT Bitcoin Trust (IBIT)
    Top Value Stocks
    Top Momentum Stocks
    Top Growth Stocks
    Top Quality Stocks
  • Learn
    Learn
    Investing Guides
    Personal Finance
    Mortgages
    Best Credit Cards
    Best Dividend Stocks
    Best Swing Trade Stocks
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
Events Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Options Profit Calculator
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Covered Call Calculator
Cash-Secured Put Calculator
Long Call Calculator
Long Put Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks

Cancer Therapies


Telix Pharmaceuticals Trial Enter Critical Stage, Analyst Predicts Big Gains
Telix Pharmaceuticals Trial Enter Critical Stage, Analyst Predicts Big Gains
Amgen Shares Dip On Light 2021 Outlook, Paused Studies
Amgen Shares Dip On Light 2021 Outlook, Paused Studies
HC Wainwright: G1 Therapeutics Is Targeting 'Potential Blockbuster' Oncology Markets
HC Wainwright: G1 Therapeutics Is Targeting 'Potential Blockbuster' Oncology Markets
Amgen Shares Dip On Light 2021 Outlook, Paused Studies
Amgen Shares Dip On Light 2021 Outlook, Paused Studies
HC Wainwright: G1 Therapeutics Is Targeting 'Potential Blockbuster' Oncology Markets
HC Wainwright: G1 Therapeutics Is Targeting 'Potential Blockbuster' Oncology Markets
Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial
Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial
Janney Says Bluebird's Therapies Are 'Encouraging,' But Stock Is Fairly Valued
Janney Says Bluebird's Therapies Are 'Encouraging,' But Stock Is Fairly Valued

Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial
Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial
Janney Says Bluebird's Therapies Are 'Encouraging,' But Stock Is Fairly Valued
Janney Says Bluebird's Therapies Are 'Encouraging,' But Stock Is Fairly Valued
Checkpoint Therapeutics Wins A New Bull As Company's 'Plan Is Quickly Coming Together'
Checkpoint Therapeutics Wins A New Bull As Company's 'Plan Is Quickly Coming Together'
Gilead's Yescarta Cancer Treatment Approved, Some Analysts Shrug
Gilead's Yescarta Cancer Treatment Approved, Some Analysts Shrug
Read More...

Cancer Therapies Recent News

Puma Biotech Makes Big Breakthrough In Breast Cancer Treatment
Puma Biotech Makes Big Breakthrough In Breast Cancer Treatment
Today's Top Mover: HTG Molecular Soars 60%
Today's Top Mover: HTG Molecular Soars 60%
Everything We Know About Merck's Keytruda
Everything We Know About Merck's Keytruda
Transgemonic Up Another 33% Following Yesterday's 295% Run
Transgemonic Up Another 33% Following Yesterday's 295% Run
FDA Approves Clovis Oncology's Ovarian Cancer Treatment
FDA Approves Clovis Oncology's Ovarian Cancer Treatment
ZIOPHARM Announces Clinical Data On Brain Cancer Drug
ZIOPHARM Announces Clinical Data On Brain Cancer Drug
Citi Sees 26% Upside In TESARO On The Strength Of Trial Data
Citi Sees 26% Upside In TESARO On The Strength Of Trial Data
Compugen Achieves Milestone Event With Bayer
Compugen Achieves Milestone Event With Bayer
Spectrum Pharmaceuticals Gains 5% After Company Confirms FDA Review Of New Drug
Spectrum Pharmaceuticals Gains 5% After Company Confirms FDA Review Of New Drug
Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
Clovis Oncology Issues Update On Rociletinib, Will Meet With FDA On April 12
Here's Why Shares Of TrovaGene Are Surging
Here's Why Shares Of TrovaGene Are Surging
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.